Tobias Kurth

Has grant

Professor and Director

Charité - Universitätsmedizin Berlin

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

ORCID

Google Scholar

Academic Page

About

Professor Tobias Kurth is the Director at Charité Universitätsmedizin Berlin, Germany. His research focuses on the intersection of epidemiology and public health, particularly in areas such as migraine, maternal health, cancer treatment, and post-infection outcomes. His recent publications include studies on the risk of Parkinson's disease, technology readiness in maternal health, and the burden of diseases such as influenza and COVID-19.

Recent Grants

Grant: Open

ALVEEG - Ambulantes Langzeit-Video-EEG für Menschen mit Anfallserkrankungen

Open Date: 2023-07-01

Close Date: 2027-06-01

Grant: Close

CovBot II

Open Date: 2021-02-01

Close Date: 2021-12-01

Grant: Close

NeTKoH - Neurologisches TeleKonsil mit Hausärzten zur Stärkung der fachärztlichen Versorgung in Vorpommern

Open Date: 2021-01-01

Close Date: 2024-12-01

Grant: Close

CovBot - „Prüfung eines KI- gestützten Coronavirus-Hotline-Assistenten zur Entlastung von öffentlichen Einrichtungen im Gesundheitswesen während Pandemien

Open Date: 2020-05-01

Close Date: 2021-04-01

Grant: Close

SMARTGEM – Smartphone-gestützte Migränetherapie

Open Date: 2018-06-01

Close Date: 2021-12-01

Tobias Kurth

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Post-infection symptoms up to 24 months after COVID-19: a matched cohort study in Berlin, Germany

Author Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study

From pilot to practice: a scoping review protocol mapping the development of AI-enabled solutions for maternal health using technology readiness levels

Trastuzumab in early curative breast cancer: A target trial emulation benchmarked against two randomized clinical trials

External validation of risk prediction models for post-stroke mortality in Berlin

Endometriosis and risk of depression among oral contraceptive users: a pooled analysis of cohort studies from 13 countries

Distinguishing Description, Prediction, and Causal Inference

Characterization of responders to transcranial direct current stimulation in disorders of consciousness: A retrospective study of 8 clinical trials.

Health-related quality of life up to two years after SARS-CoV-2 infection: a descriptive cohort study.

Measuring the disease burden of seasonal influenza in Germany 2015 - 2020 using the incidence-based disability-adjusted life years (DALYs).

Assessing the transportability of clinical prediction models for cognitive impairment using causal models

Estimation of migraine prevalence considering active and inactive states across different age groups

Economic Evaluation of a Mobile Stroke Unit Service in Germany

Adjusted horizontal stacked bar graphs (“Grotta bars”) for consistent presentation of observational stroke study results

Migraines and cardiovascular disease: mechanisms and methodological challenges

AIDS in the era of antiretroviral therapy: Changes in incidence rates and predictors of AIDS among people living with HIV under clinical care in Germany, a cohort study 1999–2018

Studying migraine as a risk factor for stroke: The importance of working with an explicit causal framework

Delineating the seasonality of varicella and its association with climate in the tropical country of Colombia.

Effect evaluation of a tele-neurologic intervention in primary care in a rural area in Germany-the NeTKoH study protocol of a stepped-wedge cluster randomized trial.

Prospective mixed-methods study evaluating the potential of a voicebot (CovBot) to relieve German health authorities during the COVID-19 infodemic.

Collaborators (13)

Christoph Stephan

Natalie Ebert

Ricarda Sophia Schulz

Heinrich J. Audebert

Ira Rohrpasser-Napierkowski

Marcus Mall

Marco Piccininni

Maria Feychting

Daniel Schulze

Jean-François Chenot

Anne Meierkord

Jana Fehr

Ralph Brinks

How do I reach out?

Meet Kite AI

Post-infection symptoms up to 24 months after COVID-19: a matched cohort study in Berlin, Germany